Rosalind Advisors, Inc. Portfolio Stock Holdings
According to the SEC 13F filed on August 14, 2026, Rosalind Advisors, Inc. disclosed 26 stock positions valued at approximately $266.23M as of quarter-end June 30, 2026. The largest holdings include DELCATH SYSTEMS, INC., FENNEC PHARMACEUTICALS INC, and XERIS BIOPHARMA HOLDINGS INC.
- Report Period
- June 30, 2026
- No. of Stocks
- 26
- Portfolio Value
- $266.23M
Holdings by Sector
Rosalind Advisors, Inc. Portfolio Holdings in Q2 2026
| Company | Symbol | Sector | Portfolio % | Shares | Change (Shares) | Change % | Value |
|---|---|---|---|---|---|---|---|
| DELCATH SYSTEMS, INC. | DCTH | Healthcare | 15.61% | 3,300,389 | - | - | $41,551,898 |
| FENNEC PHARMACEUTICALS INC | FENC | Healthcare | 12.87% | 3,188,001 | +279,800 | +9.62% | $34,271,011 |
| XERIS BIOPHARMA HOLDINGS INC | XERS | Healthcare | 8.65% | 2,908,981 | -322,719 | -9.99% | $23,039,130 |
| SAVARA INC | SVRA | Healthcare | 7.35% | 3,178,121 | -25,600 | -0.80% | $19,577,225 |
| VERASTEM INC | VSTM | Healthcare | 5.72% | 3,986,509 | +1,848,034 | +86.42% | $15,228,464 |
| X4 PHARMACEUTICALS INC | XFOR | Healthcare | 5.64% | 3,214,766 | - | - | $15,012,957 |
| EYEPOINT PHARMACEUTICALS INC | EYPT | Healthcare | 5.31% | 988,230 | -48,507 | -4.68% | $14,131,689 |
| CYBIN INC | HELP | Healthcare | 4.86% | 1,956,814 | +425,000 | +27.74% | $12,934,541 |
| VOR BIOPHARMA INC | VOR | Healthcare | 4.49% | 648,600 | -51,400 | -7.34% | $11,940,726 |
| VAXCYTE INC | PCVX | Healthcare | 4.37% | 200,000 | -90,000 | -31.03% | $11,626,000 |
| CELLDEX THERAPEUTICS INC | CLDX | Healthcare | 2.80% | 200,000 | -130,000 | -39.39% | $7,442,000 |
| BIOCRYST PHARMACEUTICALS INC | BCRX | Healthcare | 2.71% | 721,504 | -201,553 | -21.84% | $7,215,040 |
| PROFOUND MEDICAL CORP | PROF | Healthcare | 2.07% | 828,118 | - | - | $5,506,985 |
| TALPHERA INC | TLPH | Healthcare | 2.00% | 5,169,501 | +1,815,585 | +54.13% | $5,324,586 |
| ATEA PHARMACEUTICALS INC | AVIR | Healthcare | 1.87% | 1,070,550 | -101,305 | -8.64% | $4,978,058 |
| MYOMO INC | MYO | Healthcare | 1.42% | 3,637,886 | -209,386 | -5.44% | $3,783,401 |
| OVID THERAPEUTICS INC | OVID | Healthcare | 1.12% | 1,107,994 | - | - | $2,980,504 |
| NEURAXIS INC | NRXS | Healthcare | 1.12% | 508,055 | +221,917 | +77.56% | $2,971,106 |
| ABIVAX SA | ABVX | Healthcare | 1.04% | 20,869 | +20,869 | +100.00% | $2,781,003 |
| INSPIREMD INC | NSPR | Healthcare | 1.03% | 3,905,743 | - | - | $2,734,411 |
| BIOFRONTERA INC | BFRI | Healthcare | 0.45% | 1,275,609 | +111,647 | +9.59% | $1,206,088 |
| KURA ONCOLOGY INC | KURA | Healthcare | 0.41% | 100,000 | - | - | $1,097,000 |
| SPRUCE BIOSCIENCES INC | SPRB | Healthcare | 0.41% | 20,000 | +20,000 | +100.00% | $1,080,000 |
| AQUESTIVE THERAPEUTICS INC | AQST | Healthcare | 0.39% | 250,000 | - | - | $1,040,000 |
| ONKURE THERAPEUTICS INC | OKUR | Healthcare | 0.26% | 150,000 | -293,763 | -66.20% | $684,000 |
| PEPGEN INC | PEPG | Healthcare | 0.24% | 350,000 | +350,000 | +100.00% | $630,000 |
Showing 26 of 26 holdings in the latest reporting period.